BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30850596)

  • 21. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
    Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z
    J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin.
    Zou L; Ding W; Zhang Y; Cheng S; Li F; Ruan R; Wei P; Qiu B
    Biomaterials; 2018 Nov; 182():1-12. PubMed ID: 30096444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery.
    Blagus T; Markelc B; Cemazar M; Kosjek T; Preat V; Miklavcic D; Sersa G
    J Control Release; 2013 Dec; 172(3):862-71. PubMed ID: 24113487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy.
    Kong M; Hou L; Wang J; Feng C; Liu Y; Cheng X; Chen X
    Chem Commun (Camb); 2015 Jan; 51(8):1453-6. PubMed ID: 25493296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
    Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
    Zhang LS; Greyner HJ; Mummert ME; Petroll WM
    J Dermatol Sci; 2009 Jul; 55(1):56-9. PubMed ID: 19346104
    [No Abstract]   [Full Text] [Related]  

  • 27. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
    Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioreducible poly(2-ethyl-2-oxazoline)-PLA-PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin.
    Gaspar VM; Baril P; Costa EC; de Melo-Diogo D; Foucher F; Queiroz JA; Sousa F; Pichon C; Correia IJ
    J Control Release; 2015 Sep; 213():175-191. PubMed ID: 26184050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma.
    Mukherjee S; Kotcherlakota R; Haque S; Bhattacharya D; Kumar JM; Chakravarty S; Patra CR
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110375. PubMed ID: 31924026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Acetyl-D-glucosamine decorated polymeric nanoparticles for targeted delivery of doxorubicin: Synthesis, characterization and in vitro evaluation.
    Tian B; Ding Y; Han J; Zhang J; Han Y; Han J
    Colloids Surf B Biointerfaces; 2015 Jun; 130():246-54. PubMed ID: 25921641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma.
    Jangdey MS; Kaur CD; Saraf S
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):904-916. PubMed ID: 30856018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing tumor penetration and targeting using size-minimized and zwitterionic nanomedicines.
    Zhang Y; Chen W; Yang C; Fan Q; Wu W; Jiang X
    J Control Release; 2016 Sep; 237():115-24. PubMed ID: 27397491
    [No Abstract]   [Full Text] [Related]  

  • 35. Biodistribution of ascorbyl palmitate loaded doxorubicin pegylated liposomes in solid tumor bearing mice.
    Jukanti R; Devraj G; Shashank AS; Devraj R
    J Microencapsul; 2011; 28(2):142-9. PubMed ID: 21265713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin-loaded dendritic-Fe
    Nigam S; Bahadur D
    Nanomedicine; 2018 Apr; 14(3):759-768. PubMed ID: 29339187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal metformin hydrochloride-loaded cubic phases: in silico formulation optimization, preparation, properties, and application for local treatment of melanoma.
    Yu X; Zhou W; Wang H; Lu S; Jin Y; Fu J
    Drug Deliv; 2019 Dec; 26(1):376-383. PubMed ID: 30905216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical Skin Cancer Therapy Using Doxorubicin-Loaded Cationic Lipid Nanoparticles and lontophoresis.
    Huber LA; Pereira TA; Ramos DN; Rezende LC; Emery FS; Sobral LM; Leopoldino AM; Lopez RF
    J Biomed Nanotechnol; 2015 Nov; 11(11):1975-88. PubMed ID: 26554156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
    Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
    Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.